Clinical Trials Browser

Recurrence, Triple Negative Breast Neoplasms

NCT05309655 2026-03-16

CROWN

Phase NA Recruiting

90 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02455791 2026-03-09

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

Phase NA Active not recruiting

43 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07136493 2026-03-05

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Phase NA Suspended

350 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07067138 2026-03-03

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Phase NA Recruiting

175 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Phase NA Suspended

5,200 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06744465 2026-02-17

NearWave Optical Molecular Monitoring

Phase NA Recruiting

15 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07226102 2026-02-04

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Phase NA Withdrawn

BreastGynecologic

Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03017573 2026-02-03

SCANDARE

Phase NA Recruiting

1,050 enrolled

BreastGynecologicHead & NeckSarcoma

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Sarcoma, Vulvar Neoplasms, Triple Negative Breast Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Phase NA Recruiting

80 enrolled

Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT02158507 2026-01-22

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Phase NA Completed

20 enrolled 10 charts

Breast

Triple Negative Breast Neoplasms

NCT06225505 2026-01-22

CUPCAKE

Phase NA Recruiting

450 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07357948 2026-01-22

WISH-OMICHIR

Phase NA Not yet recruiting

150 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06962163 2026-01-12

EXIGENCE

Phase NA Recruiting

12 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06418126 2026-01-05

TNBC-RT2023

Phase NA Active not recruiting

15 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06879704 2026-01-02

PRECISION

Phase NA Recruiting

115 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06349512 2025-12-22

FAP-IT

Phase NA Recruiting

60 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06582615 2025-12-11

MIND-TNBC

Phase NA Recruiting

60 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07258563 2025-12-02

TASTY-steering

Phase NA Recruiting

201 enrolled

BreastGenitourinary

Testicular Neoplasms, Triple Negative Breast Neoplasms

NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Phase NA Recruiting

160 enrolled

Breast

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

NCT07187674 2025-09-23

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

Phase NA Not yet recruiting

20 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Phase NA Completed

128 enrolled

BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

NCT06371274 2025-08-12

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Phase NA Recruiting

29 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase NA Active not recruiting

798 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05722795 2025-07-09

I-CONIC

Phase NA Recruiting

40 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07046455 2025-07-01

Trop-2 Targeted PET Probes in Advanced TNBC

Phase NA Recruiting

20 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06975644 2025-05-22

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

Phase NA Not yet recruiting

55 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06610097 2025-04-23

TNBC Gut Microbiota During Neoadjuvant Treatment

Phase NA Recruiting

30 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

EINSTEIN-TNBC

CROWN

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

NearWave Optical Molecular Monitoring

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

SCANDARE

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

CUPCAKE

WISH-OMICHIR

EXIGENCE

TNBC-RT2023

PRECISION

FAP-IT

MIND-TNBC

TASTY-steering

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

I-CONIC

Trop-2 Targeted PET Probes in Advanced TNBC

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

TNBC Gut Microbiota During Neoadjuvant Treatment